Teaching tolerance

References

• Rohrbach M, Klein A, Köhli-Wiesner A, Veraguth D, Scheer I, Balmer C, et al. CRIM-negative infantile Pompe disease: 42-month treatment outcome. J Inherit Metab Dis 2010; 33:751 - 7; http://dx.doi.org/10.1007/s10545-010-9209-0; PMID: 20882352
   PubMed Web of Science ®Google Scholar
• Joseph A, Munroe K, Housman M, Garman R, Richards S. Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model. Clin Exp Immunol 2008; 152:138 - 46; http://dx.doi.org/10.1111/j.1365-2249.2008.03602.x; PMID: 18307520
   PubMed Web of Science ®Google Scholar
• Garman RD, Munroe K, Richards SM. Methotrexate reduces antibody responses to recombinant human alpha-galactosidase A therapy in a mouse model of Fabry disease. Clin Exp Immunol 2004; 137:496 - 502; http://dx.doi.org/10.1111/j.1365-2249.2004.02567.x; PMID: 15320898
   PubMed Web of Science ®Google Scholar
• Moran E, Carbone F, Augusti V, Patrone F, Ballestrero A, Nencioni A. Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. Semin Hematol 2012; 49:270 - 6; http://dx.doi.org/10.1053/j.seminhematol.2012.04.004; PMID: 22726551
   PubMed Web of Science ®Google Scholar
• Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol 2010; 47:187 - 98; http://dx.doi.org/10.1053/j.seminhematol.2010.01.002; PMID: 20350666
   PubMed Web of Science ®Google Scholar
• Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, et al. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 2008; 111:715 - 22; http://dx.doi.org/10.1182/blood-2007-03-079947; PMID: 17932250
   PubMed Web of Science ®Google Scholar
• Maddur MS, Kaveri SV, Bayry J. Comparison of different IVIg preparations on IL-17 production by human Th17 cells. Autoimmun Rev 2011; 10:809 - 10; http://dx.doi.org/10.1016/j.autrev.2011.02.007; PMID: 21376142
   PubMed Web of Science ®Google Scholar
• Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol 2007; 179:5571 - 5; PMID: 17911644
   PubMed Web of Science ®Google Scholar
• Messinger YH, Mendelsohn NJ, Rhead W, Dimmock D, Hershkovitz E, Champion M, et al. Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease. Genet Med 2012; 14:135 - 42; http://dx.doi.org/10.1038/gim.2011.4; PMID: 22237443
   PubMed Web of Science ®Google Scholar
• Deegan PB. Fabry disease, enzyme replacement therapy and the significance of antibody responses. J Inherit Metab Dis 2011; PMID: 22037707 http://www.springerlink.com/content/6517140513818126/
   Google Scholar
• Saint-Remy JM, Lacroix-Desmazes S, Oldenburg J. Inhibitors in haemophilia: pathophysiology. Haemophilia 2004; 10:Suppl 4 146 - 51; http://dx.doi.org/10.1111/j.1365-2516.2004.01009.x; PMID: 15479388
   PubMedGoogle Scholar
• Starzyk K, Richards S, Yee J, Smith SE, Kingma W. The long-term international safety experience of imiglucerase therapy for Gaucher disease. Mol Genet Metab 2007; 90:157 - 63; http://dx.doi.org/10.1016/j.ymgme.2006.09.003; PMID: 17079176
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3:253 - 7; http://dx.doi.org/10.1038/nri1032; PMID: 12658273
   PubMed Web of Science ®Google Scholar
• De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P, et al. Activation of natural regulatory T cells by IgG Fc-derived peptide “Tregitopes”. Blood 2008; 112:3303 - 11; http://dx.doi.org/10.1182/blood-2008-02-138073; PMID: 18660382
   PubMed Web of Science ®Google Scholar
• Soukhareva N, Jiang Y, Scott DW. Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Cell Immunol 2006; 240:41 - 6; http://dx.doi.org/10.1016/j.cellimm.2006.06.004; PMID: 16860296
   PubMed Web of Science ®Google Scholar
• Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA 2008; 105:19571 - 8; http://dx.doi.org/10.1073/pnas.0810163105; PMID: 19036920
   PubMed Web of Science ®Google Scholar
• Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008; 320:373 - 6; http://dx.doi.org/10.1126/science.1154315; PMID: 18420934
   PubMed Web of Science ®Google Scholar
• Cousens LP, Najafian N, Mingozzi F, Elyaman W, Mazer B, Moise L, et al. In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): A promising new tool for tolerance induction and treatment of autoimmunity. J Clin Immunol 2012; In press
   PubMed Web of Science ®Google Scholar
• Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 2003; 101:758 - 65; http://dx.doi.org/10.1182/blood-2002-05-1447; PMID: 12393386
   PubMed Web of Science ®Google Scholar
• Sela U, Sharabi A, Dayan M, Hershkoviz R, Mozes E. The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models. Immunology 2009; 128:Suppl e395 - 405; http://dx.doi.org/10.1111/j.1365-2567.2008.02988.x; PMID: 19040426
   PubMed Web of Science ®Google Scholar
• Hui DJ, Basner-Tschakarjan E, Pien GC, Martin WD, De Groot AS, High KA, et al. Peptide-Induced Antigen-Specific CD4+CD25+FoxP3+ T Cells Suppress Cytotoxicity T Cell Responses Directed Against the AAV Capsid. Blood 2010; 116:3769
   Google Scholar
• Bilate AM, Lafaille JJ. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 2012; 30:733 - 58; http://dx.doi.org/10.1146/annurev-immunol-020711-075043; PMID: 22224762
   PubMed Web of Science ®Google Scholar
• Durinovic-Belló I, Rosinger S, Olson JA, Congia M, Ahmad RC, Rickert M, et al. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype. Proc Natl Acad Sci USA 2006; 103:11683 - 8; http://dx.doi.org/10.1073/pnas.0603682103; PMID: 16868084
   PubMed Web of Science ®Google Scholar
• Sumida T, Kato T, Hasunuma T, Maeda T, Nishioka K, Matsumoto I. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjögren’s syndrome. Arthritis Rheum 1997; 40:2271 - 3; http://dx.doi.org/10.1002/art.1780401225; PMID: 9416868
   PubMed Web of Science ®Google Scholar
• Cobbold SP, Qin SX, Waldmann H. Reprogramming the immune system for tolerance with monoclonal antibodies. Semin Immunol 1990; 2:377 - 87; PMID: 2129511
   PubMedGoogle Scholar
• Winsor-Hines D, Merrill C, O’Mahony M, Rao PE, Cobbold SP, Waldmann H, et al. Induction of immunological tolerance/hyporesponsiveness in baboons with a nondepleting CD4 antibody. J Immunol 2004; 173:4715 - 23; PMID: 15383608
   PubMed Web of Science ®Google Scholar
• Mingozzi F, Liu YL, Dobrzynski E, Kaufhold A, Liu JH, Wang Y, et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 2003; 111:1347 - 56; PMID: 12727926
   PubMed Web of Science ®Google Scholar
• Sun B, Bird A, Young SP, Kishnani PS, Chen YT, Koeberl DD. Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Am J Hum Genet 2007; 81:1042 - 9; http://dx.doi.org/10.1086/522236; PMID: 17924344
   PubMed Web of Science ®Google Scholar
• Sun B, Kulis MD, Young SP, Hobeika AC, Li S, Bird A, et al. Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease. Mol Ther 2010; 18:353 - 60; http://dx.doi.org/10.1038/mt.2009.195; PMID: 19690517
   PubMed Web of Science ®Google Scholar
• Ziegler RJ, Bercury SD, Fidler J, Zhao MA, Foley J, Taksir TV, et al. Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice. Hum Gene Ther 2008; 19:609 - 21; http://dx.doi.org/10.1089/hum.2008.010; PMID: 18500944
   PubMed Web of Science ®Google Scholar
• Jordan SC, Toyoda M, Vo AA. Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation. Expert Rev Clin Immunol 2011; 7:341 - 8; http://dx.doi.org/10.1586/eci.11.10; PMID: 21595600
   PubMed Web of Science ®Google Scholar
• Muzaffar J, Katragadda L, Haider S, Javed A, Anaissie E, Usmani S. Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature. Int J Hematol 2012; 95:102 - 6; http://dx.doi.org/10.1007/s12185-011-0968-7; PMID: 22170228
   PubMed Web of Science ®Google Scholar
• Kubisz P, Plamenová I, Hollý P, Stasko J. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy. Med Sci Monit 2009; 15:CS105 - 11; PMID: 19488019
   PubMed Web of Science ®Google Scholar
• Klarmann D, Martinez Saguer I, Funk MB, Knoefler R, von Hentig N, Heller C, et al. Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor. Haemophilia 2008; 14:44 - 9; http://dx.doi.org/10.1111/j.1365-2516.2007.01584.x; PMID: 18081836
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Blank M, Shoenfeld Y. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus 2009; 18:884 - 8; http://dx.doi.org/10.1177/0961203309106921; PMID: 19671787
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Krauthammer A, Levy Y, Langevitz P, Shoenfeld Y. Long-Term Therapy with Intravenous Immunoglobulin is Beneficial in Patients with Autoimmune Diseases. Clin Rev Allergy Immunol 2011; PMID: 21732045 http://www.springerlink.com/content/j614131732668223/
   Google Scholar
• Dykes AC, Walker ID, Lowe GD, Tait RC. Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia 2001; 7:160 - 3; http://dx.doi.org/10.1046/j.1365-2516.2001.00489.x; PMID: 11260275
   PubMed Web of Science ®Google Scholar
• Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 2009; 46:Suppl 2 S2 - 14; http://dx.doi.org/10.1053/j.seminhematol.2008.12.005; PMID: 19245930
   PubMed Web of Science ®Google Scholar
• Provan D. Characteristics of immune thrombocytopenic purpura: a guide for clinical practice. Eur J Haematol Suppl 2009; 82:8 - 12; http://dx.doi.org/10.1111/j.1600-0609.2008.01207.x; PMID: 19200302
   PubMedGoogle Scholar
• Lozeron P, Adams D. Advances in the treatment of chronic inflammatory demyelinating neuropathies in 2010. J Neurol 2011; 258:1737 - 41; http://dx.doi.org/10.1007/s00415-011-6143-5; PMID: 21713585
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Mahdi-Rogers M. Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins. Biologics 2010; 24:45 - 9
   Google Scholar
• Elyaman W, Khoury SJ, Scott DW, De Groot AS. Potential application of tregitopes as immunomodulating agents in multiple sclerosis. Neurol Res Int 2011; 2011:256460; http://dx.doi.org/10.1155/2011/256460; PMID: 21941651
   PubMedGoogle Scholar
• Raben N, Jatkar T, Lee A, Lu N, Dwivedi S, Nagaraju K, et al. Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme. Mol Ther 2002; 6:601 - 8; http://dx.doi.org/10.1016/S1525-0016(02)90716-1; PMID: 12409258
   PubMed Web of Science ®Google Scholar
• Cresawn KO, Fraites TJ, Wasserfall C, Atkinson M, Lewis M, Porvasnik S, et al. Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II. Hum Gene Ther 2005; 16:68 - 80; http://dx.doi.org/10.1089/hum.2005.16.68; PMID: 15703490
   PubMed Web of Science ®Google Scholar
• Franco LM, Sun B, Yang X, Bird A, Zhang H, Schneider A, et al. Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol Ther 2005; 12:876 - 84; http://dx.doi.org/10.1016/j.ymthe.2005.04.024; PMID: 16005263
   PubMed Web of Science ®Google Scholar
• Sabatino DE, Mingozzi F, Hui DJ, Chen H, Colosi P, Ertl HC, et al. Identification of mouse AAV capsid-specific CD8+ T cell epitopes. Mol Ther 2005; 12:1023 - 33; http://dx.doi.org/10.1016/j.ymthe.2005.09.009; PMID: 16263332
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330 - 6; http://dx.doi.org/10.1038/ni904; PMID: 12612578
   PubMed Web of Science ®Google Scholar
• Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 2008; 3:e2705; http://dx.doi.org/10.1371/journal.pone.0002705; PMID: 18628982
   PubMed Web of Science ®Google Scholar
• Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009; 106:13439 - 44; PMID: 19666573
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057 - 61; http://dx.doi.org/10.1126/science.1079490; PMID: 12522256
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4:337 - 42; http://dx.doi.org/10.1038/ni909; PMID: 12612581
   PubMed Web of Science ®Google Scholar